1338 results found | searching for "invest"

First Previous 1 2 3 4 5 6 7 8 9 10 Next Last 
  • cheatingspouse
  • Investigation Services Malaysia MVD International is a No 1 company for the Investigation Services in Malaysia. We provide corporate investigation, security services, corporate specialist training etc at cost effective price. https://www.cheatingspouse.my/
  • cheatingspouse
  • Private Investigation Malaysia If your partner is cheating on you and you want to catch him red handed. MVD International will be a good choice for you. contact us for more details. https://www.cheatingspouse.my/
  • MedResponsive
  • Businesses can apply local marketing strategies by investing in local SEO companies to position their brand and capitalize on local market places. https://www.medresponsive.com/blog/10-best-local-marketing-strategies/
  • cheatingspouse
  • Catch Cheating Spouse Malaysia cheatingspouse.my has the best, most experienced Malaysian investigators in the industry, who specialize in infidelity, cheating spouses and are recognized experts. https://www.cheatingspouse.my/
  • josevwyat
  • Digital Surge Login Digital Surge is the best digital currency exchange for Australian citizens. The capacity to trade a massive variety of coins, use smart trading tools, and set up an SMSF makes this exchange a solid option for both novice and advanced digital currency investors. People seeking an exchange to handle their virtual assets will most likely enjoy what the exchange has to deliver. #DigitalSurgeLogin visit here https://sites.google.com/tomsazure.com/digital-surge-login/ [more]
  • jameshebrew
  • The human microbiome market is anticipated to grow at a CAGR of 24% till 2035 With the increasing concept of precision medicine, several scientists have demonstrated interest in the therapeutic manipulation of human microbiome (commonly gut bacteria) for the treatment of a wide range of disease indications. Roots Analysis has announced the addition of “The Human Microbiome Market, (4th Edition) 2022-2035” report to its list of offerings. The microbiome-based therapies pipeline features six drugs in phase III clinical development, over 200 candidates in other clinical and preclinical stages of development along with more than 60 diagnostics and screening / profiling tests that are commercialized for the detection of various diseases. However, the current microbiome market is driven by the fecal microbiota therapies approved by the FDA, particularly for the recurrent CDI and the commercialized diagnostic tests available to the patients. The human microbiome remained a largely unexplored area until 2007 when the Human Microbiome Project (HMP) was initiated. Given the role of microbiota in disease development and pathogenesis, the concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, thereby, defining a new frontier in the field of medicine. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/281/request-sample.html Key Market Insights Over 230 drug candidates are currently being developed by more than 70 drug developers Nearly 30% of the pipeline drugs are in clinical phase of development, while more than 150 drugs are in preclinical and discovery stages. Clinical stage drugs are primarily being developed for infectious diseases and digestive disorders, while candidates in preclinical and discovery stages are focused on oncological disorders. More than 75 diagnostics and screening / profiling test are available / under development Of these, around 80% of the tests are available in the market, while rest are under development. More than 40 companies are engaged in providing these tests; these are primarily based in North America (45%) and Europe (39%). It is worth highlighting that majority (68%) of the players are small companies. FMTs are the only commercially available microbiome therapies approved by the FDA These therapies are primarily used for the treatment of recurrent Clostridium difficile infection (rCDIs). It is worth mentioning that more than 400 trials have been registered for evaluating these therapies for a wide range of indications. Partnership activity in this domain has increased at a CAGR of 26%, between 2017 and 2021 Maximum number of partnerships were established in 2021, indicating a recent rise in the interest of players engaged in this domain. It is worth highlighting that majority of the deals were R&D agreements, representing over 35% of the total number of partnerships signed in the given time period. More than USD 1 billion has been invested by both private and public investors, since 2017 Of the total amount invested, over USD 563 million was raised through venture capital financing, representing over 56% of the overall funding activity in this domain. Further, 36 instances of grants / awards were also reported, wherein players collectively raised more than USD 137 million. Outsourcing has become an integral part of the microbiome and live biotherapeutics development process Presently, over 25 service providers claim to offer a multitude of contract manufacturing services for microbiome and live biotherapeutic products. It is worth noting that close to 10 firms were established post 2010 and around 45% of the players are located in Europe. Microbiome therapeutics are anticipated to capture more than 60% share of total microbiome market by 2035 As late-stage therapeutics will get approved by the FDA in the foreseen future, the microbiome therapeutics market is likely to grow at an annualized rate of 37% till 2035. It is worth mentioning that microbiome diagnostics is likely to capture 20% of the total microbiome market share by 2035. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • echtedokumente
  • With 21 years of experience in this counterfeit currency business, we have tried many ways to secretly and securely satisfy our customers, but often faced setbacks. We know that you do not come to this page by accident. We understand that you have different reasons for contacting us and wanting to buy our products. We are a very large network offering business partnerships, investments, raising capital, loans and many more business opportunities to the world. https://echtedokumentes.de/product-category/us-dollar/. Chat on WhatsApp with +39 351 169 5046 [more]
  • jameshebrew
  • Oral Proteins and Peptides Market Over the years, advances in recombinant DNA technology and ex vivo synthesis of biomolecules have led to the development and (in some cases) approval of several protein / peptide-based therapeutics. Considering the therapeutic advantages associated with proteins and peptides, this field has witnessed significant activity; researchers are actively evaluating orally bioavailable interventions. However, owing to their inherently complex structure and comparatively low stability (in in vivo conditions), proteins / peptides are predominantly administered parenterally. Recent strides in drug delivery solutions have enabled scientists to successfully explore and exploit alternative routes of drug delivery, such as transdermal, intranasal, pulmonary and oral, for protein / peptide-based therapeutics. Of these, the oral route of delivery is considered to be the most patient-friendly. This has led several companies to invest in the development of orally administered biologics. The delivery of proteins and peptides utilizes the following routes of administration. Since the approval of the first protein / peptide-based therapy (recombinant human insulin) in 1982, there has been a substantial increase in the R&D initiatives focused on such products. Earlier, majority of the biologics were administered subcutaneously. However, with the technological advancements in delivery formulations, oral delivery of therapeutic interventions has gained significant traction, prompting stakeholders to leverage their expertise in the development of orally administrable proteins / peptides. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/192/request-sample.html Although studies have reported that over XX oral drug delivery technologies have been designed so far, our research indicates that only XX% of the aforementioned technologies are currently being used to develop therapeutic proteins / peptides. Owing to the numerous advantages of oral drug delivery, including ease of administration, minimal pain and risk of drug reaction, and self-administration, we are led to believe that the oral proteins / peptide therapeutics market is anticipated to witness significant growth in the coming future. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/oral-proteins-and-peptides-market/192.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • tcgfunds
  • Growth Capital A startup is a company that is in its early stages, typically characterized by high uncertainty and risk. To grow and become successful, a startup needs access to growth capital. This capital can come from investors who are willing to take on a higher level of risk in exchange for potential rewards. There are several reasons why startups need growth capital. First, startups often lack the resources necessary to finance their operations from their own resources. Second, acquiring growth capital can help a startup expand its business rapidly and reach new markets. Third, growth capital can help a startup improve its product or service offerings. Fourth, growth capital can help a startup compensate employees and attract new talent. Fifth, growth capital can provide the financial foundation for future rounds of funding ( Series A, B, C ). For More Info:-https://www.sidehustleads.com/services/other-services/private-equity-firms-houston_i1561915 https://www.tcgfunds.com/services/growth-capital
  • citlatundt
  • This may not work for everyone. The arrangement is, where do we get that report from? Top is financially doable way to deal with surveys and you ought to investigate your audits completely.https://deriw27808.wixsite.com/my-site/post/what-made-paper-cat-litter-preferable [more]
First Previous 1 2 3 4 5 6 7 8 9 10 Next Last